Table 2 Patient-Provider Communication Regarding Drug Costs
Patient/Plan Characteristics | Thought issue of drug costs important enough to raise with MD (% strongly agree/agree) | Wants MD to consider cost when choosing drugs (% yes) | Talked with MD about amount paid for drugs (% yes) | MD switched any drug to a less expensive version because of cost (% yes) | Used any drug less often than prescribed because of cost (% yes) |
|---|---|---|---|---|---|
Overall Sample (n = 1458) | 76% | 80% | 44% | 47% | 22% |
Adjusted Percents+ | Â | Â | Â | Â | Â |
Female | 78% | 84%* | 47% | 51% | 25%* |
Male++ | 74% | 78% | 43% | 44% | 20% |
White++ | 76% | 81% | 48% | 49% | 23% |
Non-White | 77% | 80% | 37%*** | 43% | 23% |
Age 65-74 | 81%*** | 83% | 50%** | 45% | 29%*** |
Age 75++ | 70% | 79% | 41% | 51% | 16% |
Income < $25 K | 80%* | 82% | 51%*** | 47% | 27%*** |
Income $25-40 K | 78% | 84% | 49%*** | 57%* | 24%*** |
Income > $40 K++ | 72% | 78% | 37% | 41% | 17% |
Integrated Delivery System MAPD++ | 66% | 77% | 36% | 33% | 21% |
For-Profit MAPD | 81%*** | 84%* | 50%*** | 53%*** | 24% |
For-Profit PDP | 79%* | 81% | 51%** | 57%** | 26% |